Carregant...
Improving Prediction of Carcinogenicity to Reduce, Refine, and Replace the Use of Experimental Animals
Cancer risk assessment of new pharmaceuticals is crucial to protect public health. However, clinical trials lack the duration needed to clearly detect drug-related tumor emergence, and biomarkers suggestive of increased cancer risk from a drug typically are not measured in clinical trials. Therefore...
Guardat en:
| Publicat a: | J Am Assoc Lab Anim Sci |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Association for Laboratory Animal Science
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4382620/ https://ncbi.nlm.nih.gov/pubmed/25836962 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|